www.peopleofthechange.com
Click here for more information about LiqofluxPhenometrics Buy 3 Get 1 Free
Visit cricatalyst.com!Evodos Separation Technology Check out more of The Buzz spacer

Cyanotech buying Cellana’s Hawaiian demonstration facility

September 9, 2018
AlgaeIndustryMagazine.com

Cyanotech is buying Cellana’s six-acre production and research facility, known as the Kona Demonstration Facility. Photo: courtesy of biorrefineria.blogspot.com

San Diego, CA and Kailua-Kona, HI-based Cellana, Inc. has signed an Asset Purchase Agreement with Cyanotech Corporation for the sale of Cellana’s six-acre production and research facility, known as the Kona Demonstration Facility (KDF). KDF is located adjacent to Cyanotech’s existing 90-acre site at the Natural Energy Laboratory of Hawaii Authority (NELHA). The acquisition includes all existing equipment and other assets necessary to operate the facility.

The KDF has been used extensively for microalgae research and production since 2009. Following the closing of the transaction, Cyanotech expects to use the facility to expand its research and development capabilities, as well as supplement its production capacity, develop new products and explore new production techniques.

Cellana operates the KDF pursuant to a sublease agreement with NELHA. As part of the Asset Purchase Agreement, Cellana has agreed to assign this sublease agreement to Cyanotech, subject to the approval of NELHA and the State of Hawaii Board of Land and Natural Resources (BLNR). The closing of the acquisition is conditioned upon the approval of NELHA and BLNR, among other standard conditions. Cyanotech expects the transaction to close in the fourth quarter of the 2018 calendar year.

Over the past seven years, Cellana has directed over $30 million of investment, collaborative funding, and grant funding into developing and validating its ReNew™ Algae platform of high-value, non-GMO algae strains rich in omega-3 nutritional oils, proteins, pigments, polysaccharides, and fuel-grade oils. During this time, Cellana has produced over 10,000 kilograms of ReNew™ Algae at KDF in Hawaii for processing and testing of multiple high-value and high-volume biomass components, including multi-ton quantities of its leading commercial algae strain KA32.

In May, 2018, Cellana signed a term sheet for $27 million of debt-based project financing with an undisclosed project financing partner for a proposed 54-acre commercial algae facility to be located adjacent to KDF. The proposed 54-acre commercial algae facility is expected to produce 700 to 800 metric tons of KA32 algae (on a dry weight basis) annually.

“KDF was designed to allow Cellana to identify, develop, and demonstrate commercially significant yields of algae strains for large-scale commercialization,” said Martin Sabarsky, Cellana’s Chief Executive Officer. “This mission has been successfully accomplished with Cellana’s leading strain of algae, KA32, and so this is a great opportunity to reduce our current operational expenses while we sharpen our focus on commercialization with our expanding set of commercial and project financing partners.”

More Buzz…

Copyright ©2010-2020 AlgaeIndustryMagazine.com. All rights reserved. Permission required to reprint this article in its entirety. Must include copyright statement and live hyperlinks. Contact editorial@algaeindustrymagazine.com. A.I.M. accepts unsolicited manuscripts for consideration, and takes no responsibility for the validity of claims made in submitted editorial.

twittertopbarlinks_eventstopbarlinks_requesttopbarlinks_archives

From The A.I.M. Archives

— Refresh Page for More Choices
Due to the overall low thermodynamic efficiency (1 – 4%) of photosynthesis and its impact on crop productivity, substantial efforts are being made to engineer photosynthe...
Julianna Photopoulos writes in Horizon EU Research and Innovation magazine that UK start-up Skipping Rocks Lab aims to use natural materials extracted from plants and sea...
The 2019 Algae Biomass Summit, the largest algae conference in the world, kicked off Tuesday in Orlando, Florida, with opening keynote presentations and plenary discussio...
Jessica D'Lima writes in AdvancedScienceNews.com that medicine is moving towards minimally invasive procedures, which have important patient-oriented benefits such as sho...
The 2020 Algae Biomass Summit is going virtual. In light of the continued uncertainty around the global COVID-19 outbreak the Algae Biomass Organization’s board of direct...
Cody Nelson writes for MPRNews.org that a team of University of Minnesota-Duluth researchers wanted to know how shortening winters — and less ice cover on lakes — might i...
Cécile Barbière writes for Euractive.fr (translated by Rob Kirby) that, in large greenhouses formerly home to the tomatoes and cucumbers of the market gardening Groupe Ol...
Jason Huffman writes in UndercurrentNews.com that the Kampachi Company, a mariculture business focused on expanding the environmentally sound production of sashimi-grade ...
Mazda is currently involved in joint research projects and studies as part of an ongoing industry-academia-government collaboration to promote the wide-spread adoption of...
Susan Kraemer writes in solarpaces.org that to use solar thermal energy to convert farmed algae to fuel, the solar fuels research team at Australian National University (...
A nasal spray derived from algae and a plant in the tobacco family could offer a preventive measure for COVID-19. Researchers from the University of Pittsburgh (Pitt) and...
According to Vegconomist.com, advanced ingredients company Noblegen, creator of proteins, carbohydrates, and oil ingredients from the single celled microorganism Euglena ...